{"id":17706,"date":"2026-09-06T19:30:42","date_gmt":"2026-09-06T11:30:42","guid":{"rendered":"https:\/\/fotonmedix.com\/?p=17706"},"modified":"2026-09-06T19:30:42","modified_gmt":"2026-09-06T11:30:42","slug":"transscleral-photocoagulation-controls-canine-glaucoma-crisis","status":"publish","type":"post","link":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/","title":{"rendered":"La photocoagulation transscl\u00e9rale permet de ma\u00eetriser les crises de glaucome chez le chien"},"content":{"rendered":"<h1 class=\"wp-block-heading\">La photocoagulation transscl\u00e9rale permet de ma\u00eetriser les crises de glaucome chez le chien<\/h1>\n\n\n\n<p class=\"wp-block-paragraph\">Synchronized multi-wavelength delivery drives targeted ciliary body photocoagulation, balances uveoscleral microvascular drainage with aqueous humor decompression, and eliminates corneal thermal damage through microsecond duty cycle gating.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Veterinary ophthalmologists and emergency clinicians face an agonizing race against irreversible blindness when managing acute closed-angle glaucoma spikes in canine patients. An eight-year-old American Cocker Spaniel rushes into the emergency suite presenting with severe unilateral blepharospasm, episcleral venous congestion, a dilated fixed pupil, and milky corneal edema in the left eye. Tonometry registers an alarming intraocular pressure (IOP) of 58 mmHg, well past the thirty-minute threshold where irreversible retinal ganglion cell atrophy and optic nerve cupping begin. Emergency administration of intravenous mannitol and topical carbonic anhydrase inhibitors produces only brief drops in pressure before rebound spikes occur, accompanied by vomiting, extreme lethargy, and systemic electrolyte imbalances. Clinicians confronting progressive glaucomatous crises often find medical therapies exhausted within hours, facing enucleation or chemical ciliary ablation that permanently disfigures the ocular globe. Delivering targeted ciliary body photocoagulation requires high-precision Class IV energy capable of penetrating dense fibrous sclera to halt aqueous production without burning fragile uveal tissues or overheating the corneal surface.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">M\u00e9canique de la p\u00e9n\u00e9tration optique \u00e0 travers la scl\u00e8re fibreuse du chien<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Delivering therapeutic photon levels to the canine ciliary processes requires navigating dense ocular barriers. The ciliary body lies concealed beneath the pigmented episclera, the rigid scleral coat consisting of interlaced Type I collagen fibers, and the highly vascular uveal tract. Light directed transsclerally toward the ciliary processes encounters severe optical attenuation driven by Rayleigh scattering from dense extracellular collagen fibrils and Mie scattering from large cellular organelle interfaces within the deep scleral stroma.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In dense fibrous scleral connective tissue, scattering coefficients dominate optical absorption across the visible spectrum. Low-power therapeutic platforms deliver insufficient photon flux to penetrate these dense layers. Light scatters within the first few hundred micrometers of superficial conjunctiva and episcleral vessels, failing to deliver the critical energy density required to reach the pigmented ciliary epithelium four millimeters below the limbal margin. Delivering restorative and photocoagulative doses to deep target tissues requires high initial surface irradiance delivered through optimized optical pathways.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Biological dose-response principles governed by the Arndt-Schulz law dictate that underdosing leaves diseased ocular tissues unresponsive, while unmodulated continuous energy risks scleral thinning, uveal inflammation, or corneal melting. High-power Class IV systems deliver the precise photon density required to break through tough fibrous scleral envelopes while keeping superficial eye structures safely below critical thermal thresholds.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">When high-fluence photons penetrate the sclera and reach the ciliary processes, energy is selectively absorbed by melanin granules within the pigmented ciliary epithelium and vascular beds of the ciliary stroma. This creates controlled localized photocoagulation, reducing the volume of active secretory epithelial cells responsible for aqueous humor production. Downstream, adjacent non-coagulated uveoscleral outflow pathways experience photobiomodulation: cytochrome c oxidase within mitochondrial respiratory complex IV absorbs scattered photons, stimulating the dissociation of inhibitory nitric oxide, elevating adenosine triphosphate synthesis, and downregulating pro-inflammatory markers like tumor necrosis factor-alpha and matrix metalloproteinases, which helps re-establish natural fluid drainage.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Synchronisation de deux chromophores sur les spectres de 980 nm et 1 470 nm<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Canine ocular hypertensive crises present two opposing physical obstacles: persistent microvascular congestion within inflamed episcleral and ciliary blood vessels, and fluid-dense, stagnant aqueous humor accumulation within the posterior and anterior chambers. Monochromatic laser platforms cannot manage both targets effectively. Restoring ocular equilibrium requires coordinating complementary wavelengths targeting distinct biological chromophores.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La longueur d'onde de 980 nm pr\u00e9sente un pic d'absorption dans l'h\u00e9moglobine d\u00e9soxyg\u00e9n\u00e9e et oxyg\u00e9n\u00e9e, associ\u00e9 \u00e0 une interaction mod\u00e9r\u00e9e avec l'eau. Les yeux des chiens souffrant d\u2019hypertension chronique pr\u00e9sentent une stase veineuse extr\u00eame, une congestion \u00e9piscl\u00e9rale et une hypoxie microvasculaire dans toute l\u2019uv\u00e9e ant\u00e9rieure. L\u2019application d\u2019une \u00e9nergie \u00e0 980 nm induit une modulation microvasculaire photothermique localis\u00e9e, ciblant les noyaux riches en capillaires des processus ciliaires tout en d\u00e9congestionnant les r\u00e9seaux \u00e9piscl\u00e9raux engorg\u00e9s. Ce stimulus vasculaire d\u00e9clenche le passage des macrophages d\u2019un ph\u00e9notype M1 pro-inflammatoire \u00e0 un ph\u00e9notype M2 pro-r\u00e9solutif, ce qui permet d\u2019\u00e9liminer les d\u00e9bris cellulaires extravas\u00e9s et d\u2019att\u00e9nuer l\u2019uv\u00e9ite secondaire.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La longueur d\u2019onde de 1 470 nm interagit directement avec les mol\u00e9cules d\u2019eau intracellulaires et interstitielles. Son coefficient d\u2019absorption dans l\u2019eau est quarante fois sup\u00e9rieur \u00e0 celui des longueurs d\u2019onde comprises entre 800 nm et 900 nm. Le glaucome aigu se caract\u00e9rise par une r\u00e9tention massive de liquide qui \u00e9l\u00e8ve la pression intraoculaire \u00e0 des niveaux pouvant entra\u00eener la c\u00e9cit\u00e9. L'application directe d'\u00e9missions de photons \u00e0 1 470 nm excite les mol\u00e9cules d'eau, modifiant ainsi la conductivit\u00e9 hydraulique locale des tissus, ouvrant les espaces intertrab\u00e9culaires et acc\u00e9l\u00e9rant le drainage lymphatique et uv\u00e9oscl\u00e9ral afin de soulager la pression au sein des chambres oculaires engorg\u00e9es de liquide.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La coordination des \u00e9missions \u00e0 980 nm et 1 470 nm au sein d\u2019un faisceau d\u2019\u00e9mission synchronis\u00e9 cr\u00e9e une synergie clinique cibl\u00e9e. La longueur d\u2019onde de 980 nm contr\u00f4le la prolif\u00e9ration microvasculaire ciliaire et assure une photobiomodulation cellulaire, tandis que celle de 1 470 nm module de mani\u00e8re s\u00e9lective la hydraulique des fluides et \u00e9limine l\u2019\u0153d\u00e8me interstitiel qui, sans cela, diffuserait la lumi\u00e8re th\u00e9rapeutique. Les cliniciens qui pratiquent la th\u00e9rapie au laser chez les chiens s\u2019appuient sur cette double action pour contr\u00f4ler la production d\u2019humeur aqueuse tout en d\u00e9bloquant les voies d\u2019\u00e9coulement. Le recours \u00e0 cette approche \u00e0 double longueur d\u2019onde \u00e9tablit une norme de pointe pour le traitement du glaucome chez le chien, r\u00e9pondant aux exigences de p\u00e9n\u00e9tration structurelle en profondeur requises par la photobiomodulation musculo-squelettique canine.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Temps de relaxation thermique et modulation dynamique du cycle de service<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">L'application d'une puissance moyenne \u00e9lev\u00e9e sur des structures oculaires d\u00e9licates comporte un risque clinique grave : perforation scl\u00e9rale thermique et l\u00e9sions collat\u00e9rales corn\u00e9ennes. La m\u00e9lanine oculaire, les vaisseaux \u00e9piscl\u00e9raux riches en h\u00e9moglobine et les processus ciliaires pigment\u00e9s absorbent rapidement les photons, convertissant l'\u00e9nergie rayonnante en chaleur intense. Sans un contr\u00f4le temporel pr\u00e9cis, la temp\u00e9rature des tissus d\u00e9passe rapidement le seuil critique de quarante-trois degr\u00e9s Celsius, \u00e0 partir duquel les prot\u00e9ines structurelles se d\u00e9naturent, ce qui entra\u00eene un risque de r\u00e9tr\u00e9cissement scl\u00e9ral, d\u2019hyph\u00e9ma ou de d\u00e9collement de la r\u00e9tine.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pour surmonter cette barri\u00e8re thermique, il faut adapter l\u2019apport d\u2019\u00e9nergie au temps de relaxation thermique des tissus animaux. Le temps de relaxation thermique correspond \u00e0 la dur\u00e9e n\u00e9cessaire \u00e0 une couche de tissu biologique pour perdre cinquante pour cent de la chaleur accumul\u00e9e par dissipation microvasculaire naturelle. La scl\u00e8re oculaire et les tissus uv\u00e9aux pr\u00e9sentent des constantes de relaxation thermique de l\u2019ordre de la milliseconde. Le rayonnement laser \u00e0 onde continue d\u00e9verse de la chaleur dans les couches superficielles plus rapidement que le flux sanguin capillaire ne peut l'\u00e9vacuer, ce qui provoque des pics thermiques douloureux et des traumatismes oculaires graves.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les cycles de service puls\u00e9s r\u00e9solvent ce probl\u00e8me en convertissant l'\u00e9mission continue de photons en micro-impulsions rapides, s\u00e9par\u00e9es par de v\u00e9ritables pauses de relaxation thermique. Un cycle de service compris entre 10 et 25 % permet d'atteindre des puissances de cr\u00eate \u00e9lev\u00e9es capables de traverser les parois scl\u00e9rales r\u00e9sistantes et de coaguler les marges ciliaires, tandis que les pauses interm\u00e9diaires sans \u00e9mission permettent aux tissus superficiels de refroidir naturellement.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La modification de la fr\u00e9quence des impulsions entra\u00eene des effets biologiques distincts :<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les fr\u00e9quences comprises entre 10 et 100 hertz stabilisent les fibres nerveuses nociceptives p\u00e9riph\u00e9riques, att\u00e9nuant ainsi les douleurs oculaires trig\u00e9minales r\u00e9fractaires et le bl\u00e9pharospasme.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les fr\u00e9quences comprises entre 500 et 1 000 hertz stimulent des contractions lymphatiques localis\u00e9es le long des voies conjonctivales et uv\u00e9oscl\u00e9rales, permettant ainsi d'\u00e9liminer les \u00e9panchements inflammatoires persistants.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les fr\u00e9quences comprises entre 2 000 et 10 000 hertz optimisent l'absorption de la cytochrome c oxydase au sein des cellules ganglionnaires r\u00e9tiniennes endommag\u00e9es, ce qui favorise la neuroprotection et ralentit l'apoptose induite par la pression.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Le recours \u00e0 une modulation d'impulsions \u00e9quilibr\u00e9e dans le cadre d'une th\u00e9rapie laser sp\u00e9cialis\u00e9e chez le chien permet aux cliniciens d'administrer des doses volum\u00e9triques profondes \u00e0 travers des structures fibreuses denses sans provoquer de br\u00fblures tissulaires ni de l\u00e9sions intraoculaires collat\u00e9rales.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Comparaison de l'architecture des plateformes v\u00e9t\u00e9rinaires de classe IV<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Pour choisir un \u00e9quipement th\u00e9rapeutique, il est n\u00e9cessaire d'\u00e9valuer clairement les diff\u00e9rences physiques. Les stylos de faible puissance, les tapis superficiels et les unit\u00e9s chirurgicales en continu ne disposent pas de la dynamique du faisceau, de la profondeur optique et de la gestion thermique requises pour traiter les crises d'hypertension ophtalmique profonde et les maladies articulaires chroniques chez l'animal. Le choix d'un syst\u00e8me \u00e0 haute puissance adapt\u00e9 n\u00e9cessite une comparaison directe des caract\u00e9ristiques techniques.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>M\u00e9trique op\u00e9rationnelle<\/strong><\/td><td><strong>Unit\u00e9s de refroidissement \u00e0 bas niveau<\/strong><\/td><td><strong>Appareils de classe IV \u00e0 onde unique en fonctionnement continu<\/strong><\/td><td><strong>Syst\u00e8mes dynamiques de classe IV \u00e0 ondes multiples<\/strong><\/td><\/tr><\/thead><tbody><tr><td>Puissance de sortie optique maximale<\/td><td>0,2 W \u2013 0,5 W<\/td><td>10 W \u2013 15 W en fonctionnement continu<\/td><td>15 W \u2013 30 W (puissance de cr\u00eate avec d\u00e9clenchement)<\/td><\/tr><tr><td>Longueurs d'onde d'\u00e9mission<\/td><td>635 nm \u2013 810 nm (monocolore)<\/td><td>810 nm ou 980 nm (en exclusivit\u00e9)<\/td><td>980 nm + 1 470 nm synchronis\u00e9s<\/td><\/tr><tr><td>Profondeur de p\u00e9n\u00e9tration des tissus<\/td><td>de 1 mm \u00e0 3 mm<\/td><td>de 15 mm \u00e0 25 mm<\/td><td>De 40 mm \u00e0 80 mm de profondeur dans les couches oculaires ou articulaires denses<\/td><\/tr><tr><td>Risque de br\u00fblure thermique oculaire<\/td><td>Absent<\/td><td>\u00c9lev\u00e9 lors d'un mouvement lent de la pi\u00e8ce \u00e0 main<\/td><td>R\u00e9gulation par refroidissement \u00e0 cycle de service contr\u00f4l\u00e9<\/td><\/tr><tr><td>Focus clinique<\/td><td>Conjonctivite superficielle, ulc\u00e8res corn\u00e9ens<\/td><td>Entorses musculaires superficielles g\u00e9n\u00e9ralis\u00e9es<\/td><td>Acute closed-angle glaucoma, ciliary ablation<\/td><\/tr><tr><td>Dur\u00e9e de la session sur le glaucome canin<\/td><td>40 \u00e0 50 minutes (inefficace)<\/td><td>15 \u00e0 20 minutes<\/td><td>3 \u00e0 5 minutes par \u0153il<\/td><\/tr><tr><td>Cibler les chromophores cellulaires<\/td><td>Uniquement la cytochrome c oxydase<\/td><td>Cytochrome c oxydase ou h\u00e9moglobine<\/td><td>Cytochrome c oxydase, m\u00e9lanine, h\u00e9moglobine et eau<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c9quiper un h\u00f4pital v\u00e9t\u00e9rinaire de pointe d'un mat\u00e9riel alliant une puissance de pointe \u00e9lev\u00e9e \u00e0 des options de longueurs d'onde multiples permet d'assurer une profondeur de p\u00e9n\u00e9tration ad\u00e9quate dans le cadre des urgences ophtalmologiques, des l\u00e9sions tendineuses et des pathologies articulaires graves.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Protocole de cas clinique document\u00e9<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Le cas clinique document\u00e9 ci-apr\u00e8s pr\u00e9sente la photocoagulation ciliaire transscl\u00e9rale et la photobiomodulation neuroprotectrice dans un cabinet v\u00e9t\u00e9rinaire sp\u00e9cialis\u00e9 en ophtalmologie.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Case File Reference: VET-OPHTH-2026-3108<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Subject: Canine, American Cocker Spaniel, Spayed Female<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c2ge : 8 ans et 5 mois<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Weight: 11.4 kg<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Confirmed Diagnosis: Acute Primary Closed-Angle Glaucoma of the Left Eye (OS) secondary to goniodysgenesis, complicated by marked episcleral congestion, bullous keratopathy, and acute optic nerve head ischemia. Tonometry registered an intraocular pressure (IOP) of 58 mmHg in the left eye; right eye (OD) baseline measured 16 mmHg with narrow filtration angles on gonioscopy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Prior Therapy: Emergency intravenous mannitol at 1.5 g\/kg administered over thirty minutes produced a temporary drop in IOP to 38 mmHg, followed by a rebound spike to 54 mmHg six hours later. Topical dorzolamide-timolol and latanoprost drops triggered severe conjunctival hyperemia and blepharospasm without maintaining safe ocular pressures. Owner strongly declined enucleation and intraocular prosthesis due to cosmetic and surgical concerns.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Clinical Presentation: Grade 4\/5 ocular pain, severe blepharospasm, persistent rubbing of the left orbit, marked episcleral venous engorgement (ciliary flush), diffuse corneal edema obstructing anterior chamber clarity, a mydriatic pupil non-responsive to direct light, and absent menace response with preserved dazzle reflex.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Protocole complet de traitement clinique<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Index des sessions<\/strong><\/td><td><strong>Chronologie des \u00e9v\u00e9nements<\/strong><\/td><td><strong>\u00c9quilibre des longueurs d'onde (980 nm \/ 1 470 nm)<\/strong><\/td><td><strong>Puissance de cr\u00eate en fonctionnement (W)<\/strong><\/td><td><strong>Fr\u00e9quence d'impulsion et rapport cyclique<\/strong><\/td><td><strong>\u00c9nergie totale fournie (joules)<\/strong><\/td><td><strong>Fluence \u00e0 la surface scl\u00e9rale (J\/cm\u00b2)<\/strong><\/td><td><strong>Observations cliniques et \u00e9tapes cl\u00e9s en biom\u00e9canique<\/strong><\/td><\/tr><\/thead><tbody><tr><td>Session 1<\/td><td>Jour 1<\/td><td>80% \/ 20%<\/td><td>8,0 W<\/td><td>50 Hz, rapport cyclique 15%<\/td><td>960 J (24 places)<\/td><td>40 J\/spot<\/td><td>Transscleral delivery 3.5mm posterior to limbus across 270 degrees; IOP dropped from 54 mmHg to 26 mmHg at 2 hours post-procedure.<\/td><\/tr><tr><td>Session 2<\/td><td>Troisi\u00e8me jour<\/td><td>70% \/ 30%<\/td><td>6,0 W<\/td><td>50 Hz, rapport cyclique 20%<\/td><td>720 J (diffus)<\/td><td>12 J\/cm\u00b2<\/td><td>Episcleral congestion resolved by forty percent; corneal clearing initiated; IOP stabilized at 21 mmHg; blepharospasm ceased.<\/td><\/tr><tr><td>Session 3<\/td><td>Jour 6<\/td><td>65% \/ 35%<\/td><td>6,0 W<\/td><td>100 Hz, rapport cyclique 20%<\/td><td>720 J (diffus)<\/td><td>12 J\/cm\u00b2<\/td><td>Anterior chamber visible; mild aqueous flare clearing; IOP measured 18 mmHg; menace response returned positive in left eye.<\/td><\/tr><tr><td>Session 4<\/td><td>Jour 9<\/td><td>60% \/ 40%<\/td><td>6,0 W<\/td><td>250 Hz, rapport cyclique 25%<\/td><td>800 J (diffus)<\/td><td>14 J\/cm\u00b2<\/td><td>Diffuse corneal edema completely resolved; tapetal reflection sharp and clear; pupillary light reflex sluggish but present.<\/td><\/tr><tr><td>Session 5<\/td><td>14\u00e8me jour<\/td><td>50% \/ 50%<\/td><td>6,0 W<\/td><td>500 Hz, rapport cyclique 25%<\/td><td>800 J (diffus)<\/td><td>14 J\/cm\u00b2<\/td><td>IOP steady at 16 mmHg; ophthalmoscopy revealed pink optic nerve disc without deep cupping; no evidence of retinal detachment.<\/td><\/tr><tr><td>Session 6<\/td><td>Jour 19<\/td><td>50% \/ 50%<\/td><td>6,0 W<\/td><td>1 000 Hz, rapport cyclique 25%<\/td><td>800 J (diffus)<\/td><td>14 J\/cm\u00b2<\/td><td>Patient tracking dropped cotton balls accurately; ocular pain score dropped to 0\/5; topical medications tapered to once daily dorzolamide.<\/td><\/tr><tr><td>S\u00e9ance n\u00b0 7<\/td><td>Jour 25<\/td><td>40% \/ 60%<\/td><td>8,0 W<\/td><td>2 500 Hz, rapport cyclique 25%<\/td><td>900 J (diffuse)<\/td><td>15 J\/cm\u00b2<\/td><td>La transparence corn\u00e9enne a \u00e9t\u00e9 pr\u00e9serv\u00e9e ; une photobiomodulation transscl\u00e9rale prophylactique a \u00e9t\u00e9 r\u00e9alis\u00e9e sur l'\u0153il droit afin de favoriser le drainage uv\u00e9oscl\u00e9ral.<\/td><\/tr><tr><td>Session 8<\/td><td>Jour 33<\/td><td>40% \/ 60%<\/td><td>8,0 W<\/td><td>5 000 Hz, rapport cyclique 25%<\/td><td>900 J (diffuse)<\/td><td>15 J\/cm\u00b2<\/td><td>La pression intraoculaire de l'\u0153il gauche est stable \u00e0 15 mmHg ; celle de l'\u0153il droit est stable \u00e0 14 mmHg ; le chien pr\u00e9sente un comportement ludique normal \u00e0 la maison.<\/td><\/tr><tr><td>Session 9<\/td><td>Jour 45<\/td><td>50% \/ 50%<\/td><td>6,0 W<\/td><td>1 000 Hz, rapport cyclique 20%<\/td><td>600 J (diffus)<\/td><td>10 J\/cm\u00b2<\/td><td>Entr\u00e9e en phase d'entretien ; tonom\u00e9trie de r\u00e9f\u00e9rence confirmant des valeurs bilat\u00e9rales dans les limites normales ; rapport cup\/disc pr\u00e9serv\u00e9.<\/td><\/tr><tr><td>Session 10<\/td><td>Jour 60<\/td><td>50% \/ 50%<\/td><td>6,0 W<\/td><td>500 Hz, rapport cyclique 15%<\/td><td>600 J (diffus)<\/td><td>10 J\/cm\u00b2<\/td><td>Pr\u00e9servation compl\u00e8te des fonctions cliniques ; vision intacte dans les deux champs visuels ; arr\u00eat des traitements syst\u00e9miques sans rebond de la pression intraoculaire.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Le traitement a \u00e9t\u00e9 initi\u00e9 \u00e0 l\u2019aide d\u2019une sonde de contact transscl\u00e9rale \u00e0 fibres optiques sp\u00e9cialis\u00e9e, positionn\u00e9e avec pr\u00e9cision \u00e0 3,5 millim\u00e8tres en arri\u00e8re du bord limbal. Vingt-quatre points distincts ont \u00e9t\u00e9 cibl\u00e9s dans les quadrants dorsal, m\u00e9dial et lat\u00e9ral, en \u00e9pargnant les trajets post\u00e9rieurs de l\u2019art\u00e8re ciliaire longue situ\u00e9s \u00e0 trois et neuf heures. Les s\u00e9ances de photobiomodulation suivantes ont \u00e9t\u00e9 r\u00e9alis\u00e9es \u00e0 l\u2019aide d\u2019un faisceau divergent sans contact balayant les marges p\u00e9rilimbiques et orbitales afin de stimuler le drainage neurovasculaire.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">R\u00e9sultats cliniques et int\u00e9gration dans la pratique quotidienne<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Le recours exclusif \u00e0 des agents hyperosmotiques syst\u00e9miques et \u00e0 des collyres antiglaucomateux topiques en administration continue pr\u00e9sente d\u2019importantes limites cliniques. Le mannitol syst\u00e9mique procure une br\u00e8ve d\u00e9compression osmotique tout en pr\u00e9sentant de graves risques de surcharge cardiovasculaire, de d\u00e9shydratation aigu\u00eb et de l\u00e9sions r\u00e9nales chez les chiens \u00e2g\u00e9s. Les analogues topiques des prostaglandines provoquent fr\u00e9quemment une uv\u00e9ite s\u00e9v\u00e8re, des br\u00fblures conjonctivales et une constriction pupillaire qui bloque l'\u00e9coulement du liquide chez les chiens pr\u00e9sentant un angle oculaire \u00e9troit. Lorsque les traitements pharmaceutiques conventionnels perdent de leur efficacit\u00e9, les v\u00e9t\u00e9rinaires sont contraints de recourir \u00e0 l\u2019\u00e9nucl\u00e9ation, \u00e0 l\u2019ablation chimique du corps ciliaire \u00e0 la gentamicine ou \u00e0 une chirurgie invasive de pose d\u2019une valve de drainage, des interventions qui comportent un risque de complications graves, de d\u00e9figuration faciale et de c\u00e9cit\u00e9 imm\u00e9diate et permanente.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La th\u00e9rapie au laser multi-longueurs d'onde de classe IV \u00e0 haute puissance offre une alternative non invasive et pr\u00e9servant les organes, qui cible les causes biologiques de l'hypers\u00e9cr\u00e9tion aqueuse et de la stagnation des fluides oculaires. La synchronisation de la stimulation microvasculaire \u00e0 980 nm avec l\u2019absorption de l\u2019eau \u00e0 1 470 nm permet d\u2019acheminer des photons th\u00e9rapeutiques \u00e0 travers la scl\u00e8re, directement vers les processus ciliaires hyperactifs et les voies uv\u00e9oscl\u00e9rales congestionn\u00e9es. La production d\u2019humeur aqueuse diminue, la circulation microvasculaire collat\u00e9rale \u00e9limine les toxines m\u00e9taboliques isch\u00e9miques, et le liquide intraoculaire stagnant s\u2019\u00e9coule par les voies uv\u00e9oscl\u00e9rales stimul\u00e9es sans endommager la surface corn\u00e9enne.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L'int\u00e9gration de plateformes laser v\u00e9t\u00e9rinaires de pointe dans les processus de soins d'urgence et de sp\u00e9cialit\u00e9 des cliniques am\u00e9liore les capacit\u00e9s des \u00e9tablissements et les r\u00e9sultats pour les patients. Les interventions durent moins de cinq minutes sans n\u00e9cessiter d'incisions chirurgicales profondes, et la pression intraoculaire revient \u00e0 des valeurs normales en quelques heures. Les chiens conservent leur fonction visuelle et leur int\u00e9grit\u00e9 anatomique sans avoir \u00e0 supporter le fardeau permanent de m\u00e9dicaments toxiques, \u00e9pargnant ainsi aux propri\u00e9taires la douleur de voir leur animal devenir aveugle ou subir une ablation de l'\u0153il. L'adoption d'une technologie laser haute performance dote les \u00e9tablissements v\u00e9t\u00e9rinaires modernes d'une base th\u00e9rapeutique fiable et \u00e9tay\u00e9e par des donn\u00e9es scientifiques, permettant de prendre en charge les urgences oculaires et de pr\u00e9server la vue des chiens tout au long de leur vie.<\/p>","protected":false},"excerpt":{"rendered":"<p>Transscleral Photocoagulation Controls Canine Glaucoma Crisis Synchronized multi-wavelength delivery drives targeted ciliary body photocoagulation, balances uveoscleral microvascular drainage with aqueous humor decompression, and eliminates corneal thermal damage through microsecond duty cycle gating. Veterinary ophthalmologists and emergency clinicians face an agonizing race against irreversible blindness when managing acute closed-angle glaucoma spikes in canine patients. An eight-year-old [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"themepark_post_bcolor":"#f5f5f5","themepark_post_width":"1022px","themepark_post_img":"","themepark_post_img_po":"left","themepark_post_img_re":false,"themepark_post_img_cover":false,"themepark_post_img_fixed":false,"themepark_post_hide_title":false,"themepark_post_main_b":"","themepark_post_main_p":100,"themepark_paddingblock":false,"slim_seo":{"title":"Canine Glaucoma Transscleral Laser Therapy","description":"Control acute canine glaucoma spikes and lower intraocular pressure using dual-wavelength Class IV laser therapy engineered for deep tissue recovery."},"_geo_short_summary":"","_geo_structured_desc":"","_geo_faqs":"","_geo_key_points":"","_geo_target_audience":"","_geo_content_type":"","_geo_last_modified":"","_geo_version":0,"themepark_seo_title":"","themepark_seo_description":"","_slim_seo_primary_term_category":0,"_slim_seo_primary_term_post_tag":0,"footnotes":""},"categories":[19],"tags":[868,844],"class_list":["post-17706","post","type-post","status-publish","format-standard","hentry","category-industry-news","tag-dog-laser","tag-dog-laser-therapy"],"metadata":{"_edit_lock":["1788427290:1"],"wpil_sync_report3":["1"],"_edit_last":["1"],"_aioseo_title":[null],"_aioseo_description":[null],"_aioseo_og_title":[""],"_aioseo_og_description":[""],"_aioseo_og_article_section":[""],"_aioseo_twitter_title":[""],"_aioseo_twitter_description":[""],"_aioseo_keywords":["a:0:{}"],"_aioseo_og_article_tags":["a:0:{}"],"catce":["sidebar-widgets4"],"slim_seo":["a:2:{s:5:\"title\";s:42:\"Canine Glaucoma Transscleral Laser Therapy\";s:11:\"description\";s:149:\"Control acute canine glaucoma spikes and lower intraocular pressure using dual-wavelength Class IV laser therapy engineered for deep tissue recovery.\";}"],"views":["27"]},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis Synchronized multi-wavelength delivery drives targeted ciliary body photocoagulation, balances uveoscleral microvascular drainage with aqueous humor decompression, and eliminates corneal thermal damage through microsecond duty cycle gating. Veterinary ophthalmologists and emergency clinicians face an agonizing race against irreversible blindness when managing acute closed-angle glaucoma spikes in canine patients. An eight-year-old\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"fengmaiadmin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"FotonMedix |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis | FotonMedix\" \/>\n\t\t<meta property=\"og:description\" content=\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis Synchronized multi-wavelength delivery drives targeted ciliary body photocoagulation, balances uveoscleral microvascular drainage with aqueous humor decompression, and eliminates corneal thermal damage through microsecond duty cycle gating. Veterinary ophthalmologists and emergency clinicians face an agonizing race against irreversible blindness when managing acute closed-angle glaucoma spikes in canine patients. An eight-year-old\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-06T11:30:42+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-06T11:30:42+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis | FotonMedix\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis Synchronized multi-wavelength delivery drives targeted ciliary body photocoagulation, balances uveoscleral microvascular drainage with aqueous humor decompression, and eliminates corneal thermal damage through microsecond duty cycle gating. Veterinary ophthalmologists and emergency clinicians face an agonizing race against irreversible blindness when managing acute closed-angle glaucoma spikes in canine patients. An eight-year-old\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/#blogposting\",\"name\":\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis | FotonMedix\",\"headline\":\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis\",\"author\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/author\\\/fengmaiadmin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/#person\"},\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/#articleImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g\",\"width\":96,\"height\":96,\"caption\":\"fengmaiadmin\"},\"datePublished\":\"2026-09-06T19:30:42+08:00\",\"dateModified\":\"2026-09-06T19:30:42+08:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/#webpage\"},\"articleSection\":\"Industry News, Dog Laser, Dog Laser Therapy\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fotonmedix.com\\\/fr\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/industry-news\\\/#listItem\",\"name\":\"Industry News\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/industry-news\\\/#listItem\",\"position\":3,\"name\":\"Industry News\",\"item\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/industry-news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/#listItem\",\"name\":\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/#listItem\",\"position\":4,\"name\":\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/industry-news\\\/#listItem\",\"name\":\"Industry News\"}}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/author\\\/fengmaiadmin\\\/#author\",\"url\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/author\\\/fengmaiadmin\\\/\",\"name\":\"fengmaiadmin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g\",\"width\":96,\"height\":96,\"caption\":\"fengmaiadmin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/#webpage\",\"url\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/\",\"name\":\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis | FotonMedix\",\"description\":\"Transscleral Photocoagulation Controls Canine Glaucoma Crisis Synchronized multi-wavelength delivery drives targeted ciliary body photocoagulation, balances uveoscleral microvascular drainage with aqueous humor decompression, and eliminates corneal thermal damage through microsecond duty cycle gating. Veterinary ophthalmologists and emergency clinicians face an agonizing race against irreversible blindness when managing acute closed-angle glaucoma spikes in canine patients. An eight-year-old\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/author\\\/fengmaiadmin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/author\\\/fengmaiadmin\\\/#author\"},\"datePublished\":\"2026-09-06T19:30:42+08:00\",\"dateModified\":\"2026-09-06T19:30:42+08:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/\",\"name\":\"FotonMedix\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/#person\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis | FotonMedix","description":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis Synchronized multi-wavelength delivery drives targeted ciliary body photocoagulation, balances uveoscleral microvascular drainage with aqueous humor decompression, and eliminates corneal thermal damage through microsecond duty cycle gating. Veterinary ophthalmologists and emergency clinicians face an agonizing race against irreversible blindness when managing acute closed-angle glaucoma spikes in canine patients. An eight-year-old","canonical_url":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/#blogposting","name":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis | FotonMedix","headline":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis","author":{"@id":"https:\/\/fotonmedix.com\/fr\/author\/fengmaiadmin\/#author"},"publisher":{"@id":"https:\/\/fotonmedix.com\/fr\/#person"},"image":{"@type":"ImageObject","@id":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/#articleImage","url":"https:\/\/secure.gravatar.com\/avatar\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g","width":96,"height":96,"caption":"fengmaiadmin"},"datePublished":"2026-09-06T19:30:42+08:00","dateModified":"2026-09-06T19:30:42+08:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/#webpage"},"isPartOf":{"@id":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/#webpage"},"articleSection":"Industry News, Dog Laser, Dog Laser Therapy"},{"@type":"BreadcrumbList","@id":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr#listItem","position":1,"name":"Home","item":"https:\/\/fotonmedix.com\/fr","nextItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/#listItem","position":2,"name":"News","item":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/","nextItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news\/#listItem","name":"Industry News"},"previousItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news\/#listItem","position":3,"name":"Industry News","item":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/#listItem","name":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis"},"previousItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/#listItem","position":4,"name":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis","previousItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news\/#listItem","name":"Industry News"}}]},{"@type":"Person","@id":"https:\/\/fotonmedix.com\/fr\/author\/fengmaiadmin\/#author","url":"https:\/\/fotonmedix.com\/fr\/author\/fengmaiadmin\/","name":"fengmaiadmin","image":{"@type":"ImageObject","@id":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g","width":96,"height":96,"caption":"fengmaiadmin"}},{"@type":"WebPage","@id":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/#webpage","url":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/","name":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis | FotonMedix","description":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis Synchronized multi-wavelength delivery drives targeted ciliary body photocoagulation, balances uveoscleral microvascular drainage with aqueous humor decompression, and eliminates corneal thermal damage through microsecond duty cycle gating. Veterinary ophthalmologists and emergency clinicians face an agonizing race against irreversible blindness when managing acute closed-angle glaucoma spikes in canine patients. An eight-year-old","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/fotonmedix.com\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/#breadcrumblist"},"author":{"@id":"https:\/\/fotonmedix.com\/fr\/author\/fengmaiadmin\/#author"},"creator":{"@id":"https:\/\/fotonmedix.com\/fr\/author\/fengmaiadmin\/#author"},"datePublished":"2026-09-06T19:30:42+08:00","dateModified":"2026-09-06T19:30:42+08:00"},{"@type":"WebSite","@id":"https:\/\/fotonmedix.com\/fr\/#website","url":"https:\/\/fotonmedix.com\/fr\/","name":"FotonMedix","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/fotonmedix.com\/fr\/#person"}}]},"og:locale":"fr_FR","og:site_name":"FotonMedix |","og:type":"article","og:title":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis | FotonMedix","og:description":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis Synchronized multi-wavelength delivery drives targeted ciliary body photocoagulation, balances uveoscleral microvascular drainage with aqueous humor decompression, and eliminates corneal thermal damage through microsecond duty cycle gating. Veterinary ophthalmologists and emergency clinicians face an agonizing race against irreversible blindness when managing acute closed-angle glaucoma spikes in canine patients. An eight-year-old","og:url":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/","article:published_time":"2026-09-06T11:30:42+00:00","article:modified_time":"2026-09-06T11:30:42+00:00","twitter:card":"summary_large_image","twitter:title":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis | FotonMedix","twitter:description":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis Synchronized multi-wavelength delivery drives targeted ciliary body photocoagulation, balances uveoscleral microvascular drainage with aqueous humor decompression, and eliminates corneal thermal damage through microsecond duty cycle gating. Veterinary ophthalmologists and emergency clinicians face an agonizing race against irreversible blindness when managing acute closed-angle glaucoma spikes in canine patients. An eight-year-old"},"aioseo_meta_data":{"post_id":"17706","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":null,"breadcrumb_settings":null,"limit_modified_date":false,"reviewed_by":null,"open_ai":null,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-09-03 09:21:26","updated":"2026-09-06 12:17:47","focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fotonmedix.com\/fr\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news\/\" title=\"Industry News\">Industry News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tTransscleral Photocoagulation Controls Canine Glaucoma Crisis\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/fotonmedix.com\/fr"},{"label":"News","link":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/"},{"label":"Industry News","link":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news\/"},{"label":"Transscleral Photocoagulation Controls Canine Glaucoma Crisis","link":"https:\/\/fotonmedix.com\/fr\/transscleral-photocoagulation-controls-canine-glaucoma-crisis.html\/"}],"medium_url":false,"thumbnail_url":false,"full_url":false,"_links":{"self":[{"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/posts\/17706","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/comments?post=17706"}],"version-history":[{"count":1,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/posts\/17706\/revisions"}],"predecessor-version":[{"id":17707,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/posts\/17706\/revisions\/17707"}],"wp:attachment":[{"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/media?parent=17706"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/categories?post=17706"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/tags?post=17706"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}